CJC-1295

CJC-1295 (Without DAC) is a synthetic growth hormone-releasing hormone (GHRH) analog widely studied for its ability to stimulate the body’s natural production of growth hormone through activation of the pituitary gland. Unlike the DAC-modified version, CJC-1295 without DAC has a shorter half-life, making it an ideal research compound for investigating natural pulsatile growth hormone release and the physiological effects of shorter-duration GHRH stimulation.

Researchers investigate CJC-1295 without DAC for its potential role in promoting endogenous growth hormone secretion, protein synthesis, lean muscle development, tissue regeneration, cellular repair, and metabolic regulation. Its shorter duration of activity allows scientists to study more physiologic patterns of growth hormone release, making it valuable in research involving endocrine function, exercise physiology, and anabolic signaling.

In addition, CJC-1295 without DAC is commonly studied for its influence on body composition, fat metabolism, recovery mechanisms, healthy aging, and overall metabolic health. Its distinct pharmacokinetic profile makes it an important research peptide for exploring growth hormone physiology, regenerative medicine, and the body’s natural endocrine responses while providing flexibility in experimental dosing protocols.